CN106581399A - 一种治疗心脑血管疾病用胶囊及其制作方法 - Google Patents
一种治疗心脑血管疾病用胶囊及其制作方法 Download PDFInfo
- Publication number
- CN106581399A CN106581399A CN201710020510.9A CN201710020510A CN106581399A CN 106581399 A CN106581399 A CN 106581399A CN 201710020510 A CN201710020510 A CN 201710020510A CN 106581399 A CN106581399 A CN 106581399A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- capsule
- filtrate
- cardiovascular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000002526 effect on cardiovascular system Effects 0.000 title claims abstract description 38
- 239000002775 capsule Substances 0.000 title claims abstract description 21
- 208000024172 Cardiovascular disease Diseases 0.000 title claims abstract description 19
- 208000026106 cerebrovascular disease Diseases 0.000 title claims abstract description 19
- 238000000034 method Methods 0.000 title claims abstract description 6
- 241000208340 Araliaceae Species 0.000 claims abstract description 11
- 241000218176 Corydalis Species 0.000 claims abstract description 11
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 11
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 11
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 11
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 11
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 11
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 11
- 210000003056 antler Anatomy 0.000 claims abstract description 11
- 235000008434 ginseng Nutrition 0.000 claims abstract description 11
- 239000000706 filtrate Substances 0.000 claims description 24
- 239000002671 adjuvant Substances 0.000 claims description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 17
- 239000004615 ingredient Substances 0.000 claims description 15
- 241000283007 Cervus nippon Species 0.000 claims description 10
- 241000218628 Ginkgo Species 0.000 claims description 10
- 244000153234 Hibiscus abelmoschus Species 0.000 claims description 10
- 241000237636 Pheretima Species 0.000 claims description 10
- 241000283956 Manis Species 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 238000001514 detection method Methods 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 3
- 238000005469 granulation Methods 0.000 claims description 3
- 230000003179 granulation Effects 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 238000010025 steaming Methods 0.000 claims description 3
- 239000004575 stone Substances 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 23
- 210000004369 blood Anatomy 0.000 abstract description 22
- 230000000694 effects Effects 0.000 abstract description 18
- 239000003814 drug Substances 0.000 abstract description 12
- 210000002216 heart Anatomy 0.000 abstract description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 9
- 201000010099 disease Diseases 0.000 abstract description 7
- 229940079593 drug Drugs 0.000 abstract description 4
- 231100000957 no side effect Toxicity 0.000 abstract description 4
- 208000002381 Brain Hypoxia Diseases 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 3
- 230000008021 deposition Effects 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract 6
- 244000001632 Acorus gramineus Species 0.000 abstract 1
- 235000013073 Acorus gramineus Nutrition 0.000 abstract 1
- 244000306301 Caesalpinia sappan Species 0.000 abstract 1
- 235000015162 Caesalpinia sappan Nutrition 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 244000124209 Crocus sativus Species 0.000 abstract 1
- 235000015655 Crocus sativus Nutrition 0.000 abstract 1
- 241000934790 Daphne mezereum Species 0.000 abstract 1
- 241000402754 Erythranthe moschata Species 0.000 abstract 1
- 241001289529 Fallopia multiflora Species 0.000 abstract 1
- 241001547127 Fritillaria cirrhosa Species 0.000 abstract 1
- 244000194101 Ginkgo biloba Species 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 241000243684 Lumbricus Species 0.000 abstract 1
- 241000283966 Pholidota <mammal> Species 0.000 abstract 1
- 244000086363 Pterocarpus indicus Species 0.000 abstract 1
- 235000009984 Pterocarpus indicus Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000002023 wood Substances 0.000 abstract 1
- 230000017531 blood circulation Effects 0.000 description 14
- 230000001737 promoting effect Effects 0.000 description 13
- 210000004185 liver Anatomy 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 8
- 230000006870 function Effects 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 206010002383 Angina Pectoris Diseases 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 206010025482 malaise Diseases 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 206010033557 Palpitations Diseases 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 208000029078 coronary artery disease Diseases 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 210000002435 tendon Anatomy 0.000 description 3
- 206010008479 Chest Pain Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010040007 Sense of oppression Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000010247 heart contraction Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- FLNXBVJLPJNOSI-UHFFFAOYSA-N 1-[2-[(4-chlorophenyl)-phenylmethoxy]ethyl]piperidine Chemical compound C1=CC(Cl)=CC=C1C(C=1C=CC=CC=1)OCCN1CCCCC1 FLNXBVJLPJNOSI-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010061751 Cerebrovascular stenosis Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940127218 antiplatelet drug Drugs 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 239000000480 calcium channel blocker Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 229960002544 cloperastine Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000003087 receptor blocking agent Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
- A61K36/835—Aquilaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Endocrinology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Marine Sciences & Fisheries (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗心脑血管疾病用胶囊,包括以下重量份配比的组分:主料:人参5~15、三七参5~20、藏红花5~15、梅花鹿茸5~12、刁海龙5~12、穿山甲5~15、川贝母5~12、沉香3~10、麝香1~5;辅料:鸡血藤1.5~2.5、紫丹参1.5~2.5、何首乌1.5~2.5、野山楂2.5~3.5、银杏叶1.5~2.5、川芎0.5~1.5、赤芍0.5~1.5、降香0.5~1.5、元胡0.5~1.5、苏木0.5~1.5、石菖蒲0.5~1.5、地龙0.5~1.5;所述主料与所述辅料的重量份配比为1:1~1:3。还公开了上述胶囊的制作方法,使这些药物功效产生协同作用,快速祛瘀,改善心脑缺氧,去除心脑血管淤阻沉积,扩通心脑血管的狭窄部,与目前市场上使用的同作用药物相比,具有无副作用,标本兼治,成本较低的优点。
Description
技术领域
本发明涉及一种治疗心脑血管疾病用胶囊,还涉及该治疗心脑血管疾病用胶囊的制作方法。
背景技术
随着人们生活节奏的加快,人们的生活环境的变化,越来越多的人们患有心脑血管方面的疾病,心脑血管狭窄的产生到发病时期,是多种因素造成的,脑血管疾病,是死亡率、致残率较高的顽症,使人们承受世大的恐惧和痛苦。目前临床上无论西医或是中医,在对心脑血管病的治疗中,扩通心脑血管狭窄的效果不尽理想。市场上治疗冠心病、心绞痛、心肌梗塞的硝酸酯类,钙拮抗剂、受体阻滞剂以及抗血小板药都有很大的副作用。随着生活节奏的加快,心脑血管疾病的患病率、发病率、死亡率逐年上升,严重威胁着人类的健康和生命。
发明内容
本发明所要解决的技术问题是提供一种治疗效果好、无副作用的治疗心脑血管疾病用胶囊。
为解决上述技术问题,本发明的技术方案是:一种治疗心脑血管疾病用胶囊,包括以下重量份配比的组分:
主料:人参5~15、三七参5~20、藏红花5~15、梅花鹿茸5~12、刁海龙5~12、穿山甲5~15、川贝母5~12、沉香3~10、麝香1~5;
辅料:鸡血藤1.5~2.5、紫丹参1.5~2.5、何首乌1.5~2.5、野山楂2.5~3.5、银杏叶1.5~2.5、川芎0.5~1.5、赤芍0.5~1.5、降香0.5~1.5、元胡0.5~1.5、苏木0.5~1.5、石菖蒲0.5~1.5、地龙0.5~1.5;
所述主料与所述辅料的重量份配比为1:1~1:3。
作为优选的技术方案,包括以下重量份配比的组分:
主料:人参10、三七参15、藏红花10、梅花鹿茸8、刁海龙8、穿山甲10、川贝母8、沉香7、麝香3;
辅料:鸡血藤2、紫丹参2、何首乌2、野山楂3、银杏叶2、川芎1、赤芍1、降香1、元胡1、苏木1、石菖蒲1、地龙1;
所述主料与所述辅料的重量份配比为1~2.5。
本发明还涉及上述治疗心脑血管疾病用胶囊的制作方法,包括以下步骤:
步骤一、主料粉碎
取重量配比的份人参、三七参、藏红花、梅花鹿茸、刁海龙、穿山甲、川贝母、沉香和麝香混合粉碎,并利用75~85目的分选筛进行筛选,备用;
步骤二、辅料浸泡
取重量配比的鸡血藤、紫丹参、何首乌、野山楂、银杏叶、川芎、赤芍、降香、元胡、苏木、石菖蒲和地龙,加15倍量的水进行浸泡,浸泡时间为3.5~4.5个时;
步骤三、煎煮
将步骤二浸泡好的辅料进行煎煮两次,第一次煎煮时间为1.2~1.6小时,第二次煎煮时间为0.8~1.2小时,将两次蒸煮的药液分别进行过滤后合并滤液;
步骤四、浓缩
将步骤三制得的滤液通过加热进行浓缩,滤液浓缩至相对密度为1.15~1.20稠膏状,该相对密度的检测温度为滤液为75~85℃时;
步骤五、加醇
向步骤四制得的稠膏内添加乙醇,使含醇量为55~65%,静置至少24小时,滤过,滤液回收乙醇;
步骤六、干燥粉碎
将步骤五制得的滤液进行浓缩,滤液浓缩至相对密度为1.15~1.20浸膏状,该相对密度的检测温度为滤液为75~85℃时,将浸膏进行减压干燥粉碎,并利用90~110目的分选筛进行筛选;
步骤七、混合成型
将步骤一制得的粉料与步骤六的粉料按照1:2.5的比例进行混合,制粒装入胶囊。
药理药效:
人参性平、味甘、微苦,微温。归脾、肺经。功效:大补元气,复脉固脱,补脾益肺,生津止渴,安神益智。主治:劳伤虚损、食少、倦怠、虚咳喘促,一切气血津液不足之证;三七参扩张血管、降低血压,改善微循环,增加血流量,预防和治疗心脑组织缺血、缺氧症、抑制动脉硬化;藏红花的主要作用在于血,具有养血、活血、补血、行血、理血等功能。此外,藏红花还具有活血化瘀、凉血解毒、解郁安神、美容养颜等功效,对治疗心脑血管疾病、调节肝肾功能、调三高、抗肿瘤癌症等疗效显著;梅花鹿茸甘咸、温,补精髓,助肾阳,强筋健骨,肾虚、头晕、耳聋、目暗、阳痿、遗精、腰膝痿弱、虚寒带下及久病虚损等症,可降低血压,使心脏收缩振幅变小,心率减慢,外周血管扩张,中等剂量能引起心脏收缩显著增强,收缩幅度变大,心率加快,从而使心输出量增加;刁海龙咸甘,温,甘,温,无毒,味咸,用于老人及衰弱者之精神衰惫,治血气痛;穿山甲用于宣通脏腑,疏畅经络,透达关窍,开血凝,散血聚,消肿排脓,活血下乳;川贝母清热润肺,化痰止咳,用于肺热燥咳,干咳少痰,阴虚劳嗽,咯痰带血,治虚劳咳嗽、吐痰咯血、心胸郁街、肺痿;沉香气味辛,微温,无毒,主治:风水毒肿,去恶气;主心腹痛,霍乱中恶,邪鬼疰气,清人神;调中,补五脏,益精壮阳,暖腰膝,止转筋吐泻冷气,破症癖,冷风麻痹,骨节不任,风湿皮肤瘙痒,气痢;补脾胃,益气和神,功效:行气止痛,温中止呕,纳气平喘。用于胸腹胀闷疼痛;麝香具有开窍醒神,活血散结,止痛消肿,主治血瘀经闭,痛经,积聚;鸡血藤性味归经,苦、甘,温,归肝、肾经,功能主治补血,活血,通络,有行气、扶风、活血的效用,根入药,有舒筋活血的功能;紫丹参主要功效为活血化瘀、凉血消痈、除烦安神,主治心脉瘀阻胸痹心痛、心悸怔仲、失眠;何首乌补肝肾,益精血,乌须发,强筋骨功效相关的药理作用是促进造血功能,提高机体免疫功能,降血脂,抗动脉粥样硬化,保肝;野山楂益气养阴活血、健脾养胃、清心安神;银杏叶性味甘苦涩平,有益心敛肺、化湿止泻等功效,可改善心血管及周围血管循环功能,对心肌缺血有改善作用,具有促进记忆力、改善脑功能的作用,此外,还能降低血黏度、清除自由基;川芎活血行气,可用于冠心病心绞痛,症见胸闷憋气、心前区压痛频繁发作者;赤芍气微香,味微香甜,功能活血化瘀,理气止痛,有扩张冠状动脉,增加血流量的作用,用于冠心病的胸闷,心绞痛,高脂血症;降香性味辛,温,归经入心包,肝经,治冠心病疗效较好,能减轻症状;元胡性味辛、苦、温,归肝、脾、心经,功效活血、行气、止痛;苏木归心、肝、胃、大肠经,功效活血祛瘀,消肿定痛;石菖蒲化湿开胃,开窍豁痰,醒神益智,理气,活血,散风,去湿,可治疗心胸烦闷;地龙性寒,味咸,清热、平肝、止喘、通络,归肝、胃、肺、膀胱经,功能清热平肝、熄风止痉、平喘、利尿、通络除痹,有良好的定咳平喘、通络的作用。
由于采用了上述技术方案,本发明使这些药物功效产生协同作用,快速祛瘀,改善心脑缺氧,去除心脑血管淤阻沉积,扩通心脑血管的狭窄部,与目前市场上使用的同作用药物相比,具有无副作用,标本兼治,成本较低的优点。
具体实施方式
下面结合实施例进一步阐述本发明。在下面的详细描述中,只通过说明的方式描述了本发明的某些示范性实施例。毋庸置疑,本领域的普通技术人员可以认识到,在不偏离本发明的精神和范围的情况下,可以用各种不同的方式对所描述的实施例进行修正。因此,描述在本质上是说明性的,而不是用于限制权利要求的保护范围。
一种治疗心脑血管疾病用胶囊,包括以下重量份配比的组分:
主料:人参5~15、三七参5~20、藏红花5~15、梅花鹿茸5~12、刁海龙5~12、穿山甲5~15、川贝母5~12、沉香3~10、麝香1~5;
辅料:鸡血藤1.5~2.5、紫丹参1.5~2.5、何首乌1.5~2.5、野山楂2.5~3.5、银杏叶1.5~2.5、川芎0.5~1.5、赤芍0.5~1.5、降香0.5~1.5、元胡0.5~1.5、苏木0.5~1.5、石菖蒲0.5~1.5、地龙0.5~1.5;
所述主料与所述辅料的重量份配比为1:1~1:3。
本实施例所述的治疗心脑血管疾病用胶囊,以包括以下重量份配比的组分为例,进行详细说明,
主料:人参10、三七参15、藏红花10、梅花鹿茸8、刁海龙8、穿山甲10、川贝母8、沉香7、麝香3;
辅料:鸡血藤2、紫丹参2、何首乌2、野山楂3、银杏叶2、川芎1、赤芍1、降香1、元胡1、苏木1、石菖蒲1、地龙1;
所述主料与所述辅料的重量份配比为1~2.5。
本实施例还涉及上述治疗心脑血管疾病用胶囊的制作方法,包括以下步骤:
步骤一、主料粉碎
取重量配比的份人参、三七参、藏红花、梅花鹿茸、刁海龙、穿山甲、川贝母、沉香和麝香混合粉碎,并利用80目的分选筛进行筛选,备用;
步骤二、辅料浸泡
取重量配比的鸡血藤、紫丹参、何首乌、野山楂、银杏叶、川芎、赤芍、降香、元胡、苏木、石菖蒲和地龙,加15倍量的水进行浸泡,浸泡时间为4个时;
步骤三、煎煮
将步骤二浸泡好的辅料进行煎煮两次,第一次煎煮时间为1.5小时,第二次煎煮时间为1小时,将两次蒸煮的药液分别进行过滤后合并滤液;
步骤四、浓缩
将步骤三制得的滤液通过加热进行浓缩,滤液浓缩至相对密度为1.18稠膏状,该相对密度的检测温度为滤液为80℃时;
步骤五、加醇
向步骤四制得的稠膏内添加乙醇,使含醇量为60%,静置至少24小时,滤过,滤液回收乙醇;
步骤六、干燥粉碎
将步骤五制得的滤液进行浓缩,滤液浓缩至相对密度为1.18浸膏状,该相对密度的检测温度为滤液为80℃时,将浸膏进行减压干燥粉碎,并利用100目的分选筛进行筛选;
步骤七、混合成型
将步骤一制得的粉料与步骤六的粉料按照1:2.5的比例进行混合,制粒装入胶囊。
治疗范围:
主治心脑血管狭窄,扩通心脑血管,防治心脑血管病。
用法用量:
(1)对于心脑血管狭窄较轻者,属于长期用药每日两次,每次2-4粒,饭后温开水送服,一个月为一疗程,至少服用三个疗程;
(2)对于心脑血管狭窄较轻重,属于长期用药每日三次,每次2-4粒,饭后温开水送服,一个月为一疗程,至少服用七个疗程;
试验观察一般资料:
前后共试治65人,其中男性44人,女性21人,年龄在50~70岁,经县级及以上医院确诊并住院治疗,疗效欠佳,后经本发明药剂治疗,具有可比性。
诊断标准:
所有病例全部按医院检查确诊报告,确定诊断。
治疗方法:
所有病人在自愿求治的情况下,服用本发明药剂,按照用法用量进行对应分配药量和确定治疗疗程。
疗效评定标准:
治愈:心脑血管狭窄减少30%,心慌气短、面部抖动等症状消失;
有效:心脑血管狭窄减少20%,胸闷憋气等不适症状明显减轻;
差效:心脑血管狭窄减少不明显,不适症状无明显改善。
结果分析:所有经试治的65人,治愈44人,有效19人,差效2人,总有效率96.9%,治愈率67.7%,表明效果明显,患者满意度高。
典型病例:
1、郑某某,女,65岁,江陵县沙岗镇人,2010年患心脑血管病,每年至少住院两次,对心血管进行治疗,每次出院后不久仍存在心慌气短,经服用本发明药剂十日后自身感觉好转,连续服用四个月,四个月后检查,原狭窄70%的心血管减少8%,又四个月后检查又减少15%,七个月后检查减少20%,一年后心血管基本畅通,血压正常。
2、孙某某,男,55岁,保康县马良镇人,2011年患脑血管狭窄50%,经多次住院,出院不久仍心慌气短,胸闷憋气,服本发明药剂五日后感觉好转,三个月后不适症状明显消失,三个月后检查减少15%,七年后又减少15%,一年后心血管基本畅通,血压正常。
3、王某某,男,46岁,汉川市麻河镇人,2014年患心血管病,狭窄30%,剧烈活动后,胸闷气短。经用本发明药剂,三个月后不适症状消失,半年后经检查,狭窄减少8%,五个月后又减少5%,一年后检查又减少6%,心血管狭窄基本正常。
本发明使这些药物功效产生协同作用,快速祛瘀,改善心脑缺氧,去除心脑血管淤阻沉积,扩通心脑血管的狭窄部,与目前市场上使用的同作用药物相比,具有无副作用,标本兼治,成本较低的有点。
本发明的描述是为了示例和描述起见而给出的,而并不是无遗漏的或者将本发明限于所公开的形式。很多修改和变化对于本领域的普通技术人员而言是显然的。选择和描述实施例是为了更好说明本发明的原理和实际应用,并且使本领域的普通技术人员能够理解本发明从而设计适于特定用途的带有各种修改的各种实施例。
Claims (3)
1.一种治疗心脑血管疾病用胶囊,其特征在于,包括以下重量份配比的组分:
主料:人参5~15、三七参5~20、藏红花5~15、梅花鹿茸5~12、刁海龙5~12、穿山甲5~15、川贝母5~12、沉香3~10、麝香1~5;
辅料:鸡血藤1.5~2.5、紫丹参1.5~2.5、何首乌1.5~2.5、野山楂2.5~3.5、银杏叶1.5~2.5、川芎0.5~1.5、赤芍0.5~1.5、降香0.5~1.5、元胡0.5~1.5、苏木0.5~1.5、石菖蒲0.5~1.5、地龙0.5~1.5;
所述主料与所述辅料的重量份配比为1:1~1:3。
2.如权利要求1所述的一种治疗心脑血管疾病用胶囊,其特征在于:包括以下重量份配比的组分:
主料:人参10、三七参15、藏红花10、梅花鹿茸8、刁海龙8、穿山甲10、川贝母8、沉香7、麝香3;
辅料:鸡血藤2、紫丹参2、何首乌2、野山楂3、银杏叶2、川芎1、赤芍1、降香1、元胡1、苏木1、石菖蒲1、地龙1;
所述主料与所述辅料的重量份配比为1~2.5。
3.如权利要求1所述的一种治疗心脑血管疾病用胶囊的制作方法,其特征在于,包括以下步骤:
步骤一、主料粉碎
取重量配比的份人参、三七参、藏红花、梅花鹿茸、刁海龙、穿山甲、川贝母、沉香和麝香混合粉碎,并利用75~85目的分选筛进行筛选,备用;
步骤二、辅料浸泡
取重量配比的鸡血藤、紫丹参、何首乌、野山楂、银杏叶、川芎、赤芍、降香、元胡、苏木、石菖蒲和地龙,加15倍量的水进行浸泡,浸泡时间为3.5~4.5个时;
步骤三、煎煮
将步骤二浸泡好的辅料进行煎煮两次,第一次煎煮时间为1.2~1.6小时,第二次煎煮时间为0.8~1.2小时,将两次蒸煮的药液分别进行过滤后合并滤液;
步骤四、浓缩
将步骤三制得的滤液通过加热进行浓缩,滤液浓缩至相对密度为1.15~1.20稠膏状,该相对密度的检测温度为滤液为75~85℃时;
步骤五、加醇
向步骤四制得的稠膏内添加乙醇,使含醇量为55~65%,静置至少24小时,滤过,滤液回收乙醇;
步骤六、干燥粉碎
将步骤五制得的滤液进行浓缩,滤液浓缩至相对密度为1.15~1.20浸膏状,该相对密度的检测温度为滤液为75~85℃时,将浸膏进行减压干燥粉碎,并利用90~110目的分选筛进行筛选;
步骤七、混合成型
将步骤一制得的粉料与步骤六的粉料按照1:2.5的比例进行混合,制粒装入胶囊。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710020510.9A CN106581399A (zh) | 2017-01-12 | 2017-01-12 | 一种治疗心脑血管疾病用胶囊及其制作方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710020510.9A CN106581399A (zh) | 2017-01-12 | 2017-01-12 | 一种治疗心脑血管疾病用胶囊及其制作方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106581399A true CN106581399A (zh) | 2017-04-26 |
Family
ID=58583270
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710020510.9A Pending CN106581399A (zh) | 2017-01-12 | 2017-01-12 | 一种治疗心脑血管疾病用胶囊及其制作方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106581399A (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101181533A (zh) * | 2007-12-10 | 2008-05-21 | 张洪勇 | 治疗脑、心血管病的中药 |
CN104587087A (zh) * | 2014-12-30 | 2015-05-06 | 神威药业集团有限公司 | 一种治疗心脑血管疾病的药物组合物 |
-
2017
- 2017-01-12 CN CN201710020510.9A patent/CN106581399A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101181533A (zh) * | 2007-12-10 | 2008-05-21 | 张洪勇 | 治疗脑、心血管病的中药 |
CN104587087A (zh) * | 2014-12-30 | 2015-05-06 | 神威药业集团有限公司 | 一种治疗心脑血管疾病的药物组合物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103520654A (zh) | 一种用于治疗膝骨关节炎的中药组合物及其制备方法 | |
CN103006842B (zh) | 一种治疗中医胸痹心痛的药物 | |
CN102755626B (zh) | 一种治疗病态窦房结综合症的中药组合物及制备方法 | |
CN101040930B (zh) | 一种外用治疗腰椎间盘突出的中药组合物 | |
CN104107321A (zh) | 一种治疗冠心病的中药组合物 | |
CN106880826A (zh) | 一种治疗慢性心力衰竭的中药制剂及其制备方法 | |
CN104225532B (zh) | 治疗强直性脊柱炎的健脾温肾丸 | |
CN105902793A (zh) | 一种治疗冠心病的中药 | |
CN103417812B (zh) | 一种治疗股骨头坏死的中药组合物及其制备方法 | |
CN103083616B (zh) | 一种治疗卵巢囊肿的中药 | |
CN103690869B (zh) | 治疗肠易激综合征的中药及其制备方法 | |
CN102940745A (zh) | 一种用于治疗眼睑痉挛的丸剂 | |
CN102441133A (zh) | 一种治疗股骨头坏死的中药 | |
CN102755625B (zh) | 一种治疗心肌供血不足综合症的中药组合物及制备方法 | |
CN105395982A (zh) | 一种治疗慢性胃炎的中药组合物 | |
CN105435131A (zh) | 一种治疗慢性心衰的中药组合物及其制备方法 | |
CN104958537A (zh) | 一种治疗胃癌的中药组合物及其制备方法 | |
CN106581399A (zh) | 一种治疗心脑血管疾病用胶囊及其制作方法 | |
CN104306583A (zh) | 一种治疗月经量少的中药组合物及其制备方法 | |
CN104189714A (zh) | 一种治疗冠心病的中药胶囊 | |
CN103705733A (zh) | 一种治疗心律不齐的中药胶囊及其制备方法 | |
CN107412679A (zh) | 排毒保健品及其制备方法和应用 | |
CN106344793A (zh) | 一种治疗关节炎的中药足浴粉及其制备方法 | |
CN105920574A (zh) | 一种治疗心悸病的药物及其制备方法 | |
CN105833065A (zh) | 一种用于治疗女性内分泌失调的中药汤剂及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170426 |
|
RJ01 | Rejection of invention patent application after publication |